Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Limited Stage Small Cell Lung Cancer × Chemoradiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Limited Stage Small Cell Lung Cancer 1 Head and Neck Neoplasms 1 Carcinoma 1

Interventions

trilaciclib 1 tislelizumab 1 Sodium Chloride 1 Glucose 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04952597 2024-10-26

Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer

BeiGene

Phase 2 Completed

126 enrolled 19 charts

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡